DispenCell is an enabler for personalized medicine as it allows scientists to isolate single cells reliably and cost-effectively by reducing lab time and validation time.
25.09.2024
Innosuisse funds 33 projects as part of the Swiss Accelerator (startupticker.ch)
10.05.2023
Innosuisse Scale-up Coaching programme to boost 17 start-ups (startupticker.ch)
20.02.2023
Swiss startups accelerate precision medicine and value-based healthcare (startupticker.ch)
08.02.2023
Major business partner for SEED Biosciences (startupticker.ch)
16.12.2022
The 18 most promising biotech startups, according to investors (TOP 100)
No Jobs
SEED Biosciences - We make DispenCell
Startup Champions Seed Night 2017
DispenCell Movie
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
The venture business plan competition takes place every year and combines a competition, learning events and contact form in one. It is an initiative of the ETH Zurich, CTI and McKinsey.
The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
Website:
www.seedbiosciences.com
Headquarter:
Epalinges
Foundation Date:
September 2018
Technology:
Sectors: